HDAC4/MybL1/YAP novel signaling axis is required for pancreatic cancer metastasis to the liver

By afschroeder • November 25, 2025

Edderkaoui M, Elmadbouh OHM, Lim A, Ou Y, Hauptschein D, Guha A, Darwish A, Calsavara VF, Murali R, Bhowmick N, Osipov A, Mathison AJ, Urrutia R, Wang Q, Pandol SJ. HDAC4/MybL1/YAP novel signaling axis is required for pancreatic cancer metastasis to the liver. Int J Biol Sci. 2025 Oct 24;21(15):6907-6925. doi: 10.7150/ijbs.102132. PMID: 41281751; PMCID: PMC12631223.

Tags: Cedars Sinai DoM, Digestive Diseases, Hematology/Oncology, Publications

Sustained Effects of a 6-Week Resiliency Program for Women with Metastatic Breast Cancer: A Brief Report of a Clinical Trial

Henneghan A, Wertheimer J, Kim S, Gresham G, Shirazipour CH, Jones B, Asher A. Sustained Effects of a 6-Week Resiliency Program for Women with Metastatic[...]

CalShock: beyond the shock team, building on California’s cardiogenic shock system of care

Bell FM, Holtzman JN, Chandrakumar HP, Marogi EP, Khedraki R, Cheng R, Elliott A, Hilliard AA, Itchhaporia D, Chonde MD, Naidu SS, Egrie G, Mahmud[...]

Strategies for promoting exercise adherence within a cancer exercise recovery program: a qualitative case study

Huynh N, Cruz N, Torney C, Ruggieri R, Chang P, Asher A, Shirazipour CH. Strategies for promoting exercise adherence within a cancer exercise recovery program:[...]